Recently, a RNA aptamer SQ2 targeting ALPPL2 has been used to specifically deliver 5-fluoro-2′-deoxyuridine to pancreatic cancer cells and successfully inhibit the proliferation of recipient cells in vitro [129]. Here, ALPG is linked to familial pancreatic carcinoma.